Vitreous Tamponades Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018 – 2026
Vitreous tamponades are essentials used in
vitrectomy procedures for healing or reattachment of retina and in
vitreous dysfunction. They are majorly used in various retinal
disorders such as retinal detachment, diabetic retinopathy, retinitis
pigmentosa, retinal degeneration, vascular occlusion, macular hole,
epiretinal membrane, macular edema, uveitis, and retinopathy of
prematurity. Vitreous humor is clear and colorless fluid made up of
99% water. It occupies the space between retina and lens of the eye.
Vitreous protects the eye by holding their spherical shape and helps
to stay retina in place. In vitreous dysfunction, vitreous gets
liquefied and shrinks in size, which eventually leads to visual
impairment. As vitreous humor cannot regenerate, the cavity must be
filled with substitutes by vitrectomy surgery to treat vitreous
dysfunction. They are replaced with artificial substitutes, which
closely resembles the native vitreous in both function and structure.
The ideal vitreous substitutes should be transparent, biocompatible
and elastic. Vitreous substitutes such as Semi fluorinated alkanes
tamponades and silicone oil/semi fluorinated alkanes combinations are
more superior physically and chemically than conventional gas or
liquid tamponades. Natural polymers, hydrogel, transplant/implants,
and vitreous regeneration are new vitreous substitutes in
developmental stage.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1193
Vitreous substitutes are used as intraoperative
and postoperative tool for surgical treatment of vitreoretinal
disease. They are used as temporary fillers, permanent fillers or
used as surgical tool during short intraocular surgery.
According to the data published by National Center
for Biotechnology Information (NCBI) in January 2014, retinal
detachment is the most common vision-threatening retinal condition,
with an incidence of 1 in 10,000 individual annually, which
corresponds to around 8,000 new cases in Germany annually. Moreover,
according to the study findings by Journal of Ophthalmology in 2016,
the prevalence of retinal detachment ranges from 6.3 to 17.9 per
100,000 people annually. Increasing incidences of retinal detachment,
ophthalmic conditions, and retinal disease are expected to drive the
growth of vitreous tamponades market in near future. However,
complications associated with the conventional vitreous substitutes
hamper the vitreous tamponades market growth. The intraocular gases
have high risk of elevating intracellular pressure on the surrounding
retinal membrane. The widely used silicone oil shows short life cycle
and needs to be removed early, due to the complications such as
emulsification, band keratopathy, and secondary glaucoma. Heavy
silicone oil leads to significant intraocular inflammatory reactions
and may cause severe complications than conventional silicone oil.
Although polymer appears to be more biocompatible, they biodegrade
quickly. Hence, long term biocompatibility of existing vitreous
substitute material and need to develop more suitable materials is
expected to replace the existing vitreous humor, in turn boosting the
growth of vitreous tamponades market.
Vitreous tamponades market taxonomy:
By type:
Gaseous tamponades
-
Sulfur hexafluoride (SF6) gas tamponade
-
Perfluoropropane (C3F8) gas tamponade
Liquid tamponades
-
Silicone oil liquid tamponade
-
Perfluorocarbon liquid tamponade
-
Balanced salt solution
Quick filling hydrogel is expected to
replace conventional vitreous tamponades in near future
According to the recent finding by the University
of Tokyo in March 2017, new hydrogel-elastic gel was introduced in
the vitreous tamponades market. The new hydrogel is administrated in
liquid form behind the retina, which then turns into jellylike
substance in just 10 minutes. The conventionally available vitreous
substitute such as silicone oil and gas do not mix well with water,
hence they are not suitable for long term application and require
long period for gels formation, thereby making them impractical to
use during the surgery. The hydrogels have high water content and
composed of similar materials those found in soft tissue of eye.
Conventional hydrogels absorb water and swell resulting into pressure
on the surrounding retinal tissues, which eventually cause damage.
The study carried out on hydrogel implanted rabbits showed no adverse
effects even after 410 days of treatment.
The unique ability of newly developed hydrogel to
transform into gel form in very short period and low polymer
concentration makes it suitable for broader applications to treat
trauma, tumors, and vitreoretinal disease. Potential development in
vitreous substitutes are further expected to drive growth of the
vitreous tamponades market in near future.
The major players operating in the global vitreous
tamponades market includes Alcon, Inc., Carl Zeiss Meditec AG,
Fluoron GmbH, D.O.R.C. Dutch Ophthalmic Research Center B.V.,
AL.CHI.MI.A.SRL, CROMA-PHARMA GmbH, and Valeant Pharmaceuticals
International, Inc.
Request For Customization @
https://www.coherentmarketinsights.com/insight/request-customization/1193
About Coherent Market Insights:
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment